Usui Noriko | Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF)
Intensifying Daunorubicin in Induction for Patients with Core Binding Factor Leukemia
Intensified Daunorubicin in Induction Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Postremission Therapy (Double-7 Protocol) for Adult Acute Myeloid Leukemia
Early cytomegalovirus (CMV) gastrointestinal disease that developed 19 days after bone marrow transplantation, with a high-level of CMV antigenemia, of up to 1120 cells/slide
Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia
Successful Combination Therapy with Trastuzumab and Paclitaxel for Adriamycin- and Docetaxel-Resistant Inflammatory Breast Cancer
Carcinoembryonic Antigen-Producing Multiple Myeloma Detected by a Transcription-Reverse Transcription Concerted Reaction System
Toxicity and Outcome of Intensive Chemotherapy for Acute Lymphoblastic Leukemia Complicated with Turner's Syndrome
CD2^+ Tetraploid Acute Promyelocytic Leukemia Variant with Double (15 ; 17) Translocations
Septic Intramuscular Embolism in a Neutropenic Patient with Myelodysplastic Syndrome Accompanied by Asymptomatic Septic Pulmonary Emboli
Th1/Th2 Lymphocyte Balance in Patients with Aplastic Anemia
Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
Two Cases of Mediastinal Gray Zone Lymphoma
Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies : analysis of eight patients
Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes

もっと見る

スポンサーリンク